Peptides

We have developed technology to produce a highly effective low molecular weight substance with regenerative properties, peptide products , derived from embryonic tissues. This achievement is the result of 12 years of research. The production process is fully optimized, utilizing SPF eggs, which are readily available in sufficient quantities on the market bio active peptides . The production cycle takes only 24 days, and the raw material costs are low, making the process highly efficient.

Currently, we have developed three different substances that are ready for commercialization. Our primary substance, named PCPE, stands out as a promising candidate for drug development, thanks to its unique regenerative capabilities and scalability.

Our goal is to introduce to the global market a highly effective low molecular weight peptide products , renowned for its powerful tissue repair properties. This is achieved through its antioxidant, anti-inflammatory, immune-boosting, and other regenerative qualities. The peptide synthesis product offers high bioavailability, ensuring efficient absorption, and is cost-effective to produce. This combination will enable us to penetrate the mid-range price segment of the anti-aging market, providing advanced solutions at an accessible price point.

We have developed a biologically active low molecular weight peptide products derived from embryonic bird tissue, processed using proprietary know-how. This unique composition consists primarily of amino acids and bio active peptides with molecular weights of no more than 10 kDa, offering a superior profile compared to competing products. The composite substance exhibits a powerful regenerative effect on live tissues, promoting complete tissue repair.

Applications: 

Our advanced technology for creating this versatile peptide-amino acid composite, PCPE, from live embryonic tissue enables the production of highly effective products in a range of industries, including:

1. Medicine: Medical devices and dental healthcare products.

2. Cosmeceuticals: Lotions, gels, creams, and mesotherapy products.

The substance has shown significant antioxidant activity. When tested using the TEAC (Trolox Equivalent Antioxidant Capacity) method, its value reached 2.33 μmol Trolox/ml. Additionally, the total antioxidant activity, measured electrochemically with gallic acid, was high at 7.76 mg/l for gallic acid. These results underscore the substance's potent antioxidant and tissue-regenerating capabilities.

Peptide products, found in living organisms, are short chains of amino acid monomers linked by peptide bonds.

The use of peptide synthesis received prominence in molecular biology for several reasons. The first is that peptides allow the creation of peptide antibodies in animals without the need to purify the protein of interest.

Another reason is that techniques such as mass spectrometry enable the identification of proteins based on the peptide masses and sequences that result from their fragmentation.

Bio active peptides have recently been used in the study of protein structure and function. For example, synthetic peptides can be used as probes to see where protein-peptide interactions occur.

Inhibitory peptides are also used in clinical research to examine the effects of peptides on the inhibition of cancer proteins and other diseases. For example, one of the most promising applications is through peptides that target LHRH. These particular peptides act as an agonist, meaning that they bind to a cell in a way that regulates LHRH receptors. The process of inhibiting the cell receptors suggests that peptides could be beneficial in treating prostate cancer, but additional investigations and experiments are required before their cancer-fighting attributes can be considered definitive.

We offer peptides of various molecular sizes from 5 kDa to 20 kDa

Peptide products serve as the building blocks of living tissues and have been shown to prevent skin degradation caused by aging and environmental factors. This essential role has sparked ongoing interest in peptides within the anti-aging industry.

However, the peptide synthesis of monopeptides is currently expensive due to existing production methods. Additionally, combining multiple monopeptides into a single product is often cost-prohibitive for the broader market.

To create products with a balanced complex of peptides, many companies are now focusing on producing peptide complexes from organic materials. Despite this trend, the production process remains prohibitively expensive.